Investor Relations |
|
At Questcor, we are a biopharmaceutical company whose products help patients with serious, difficult-to-treat medical conditions. Our efforts are currently focused on the fields of neurology and nephrology, areas of medicine which have significant unmet medical needs.
Recent Releases
May 16, 2012
Questcor Pharmaceuticals Expands Repurchase Program
May 7, 2012
Questcor Pharmaceuticals to Present at Bank of America Merrill Lynch 2012 Health Care Conference
Apr 24, 2012
Questcor Reports First Quarter 2012 Financial Results
Events & Presentations
May 16, 2012 at 1:40 PM PT
Questcor Pharmaceuticals Presents at Bank of America Merrill Lynch 2012 Health Care Conference
Apr 24, 2012 at 4:30 PM ET
Q1 2012 Questcor Pharmaceuticals, Inc. Earnings Conference Call
| Investor Presentation |
|---|
 |
| Stock Chart | |
|---|---|
|
|
|
| Stock Quote | |
| Questcor Pharmaceuticals, Inc. | |
| Price: | 39.78 |
| Change: | + 0.40 |
| Day High: | 40.48 |
| Day Low: | 39.40 |
| Volume: | 2,173,600 |
| Delayed at least 20 minutes. Provided by eSignal. |
|
Transfer Agent
Computershare Trust Co., Inc.Phone 303-262-0600
Corporate Counsel
Stradling Yocca Carlson & RauthNewport Beach, CA
Independent Accountants
BDO USA, LLPInvestor Relations Contacts
Doug Sherk, EVC Group, 415-896-6820or
Tracy Megee, (714) 786-4205